Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patients

To report the efficacy, safety, and quality of life (QoL) on generic and innovator ibrutinib in Indian CLL patients. This was a single centre, prospective study of treatment-naive (TN), and relapsed/refractory (R/R) CLL patients receiving ibrutinib in India. The choice of innovator or generic ibruti...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Indian J Hematol Blood Transfus
Main Authors: Singh, Charanpreet, Jindal, Nishant, Youron, Padma, Malhotra, Pankaj, Prakash, Gaurav, Khadwal, Alka, Jain, Arihant, Sreedharanunni, Sreejesh, Sachdeva, Man Updesh Singh, Naseem, Shano, Varma, Neelam, Varma, Subhash, Lad, Deepesh P.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer India 2020
Assuntos:
Short Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC8012457/
https://ncbi.nlm.nih.gov/pubmed/33867740
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-020-01378-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados